Stars Rally Together Again For Stand Up To Cancer ’ s Live Broadcast On September 7

LOS ANGELES– Stand Up To Cancer (SU2C), a division of the Entertainment Industry Foundation (EIF), is proud to announce that the Hollywood community is rallying together yet again to support the sixth biennial televised fundraising special. CBS will donate one hour of commercial-free primetime to broadcast the event on Friday, Sept. 7  from 8:00 – 9:00 PM ET/PT (7:00 – 8:00 PM CT). Mahershala Ali, Kathy Bates, Katie Couric, Jennifer Garner, Tony Hale, Marg Helgenberger, Ed Helms, Ken Jeong, Marlee Matlin, Matthew McConaughey, Maria Menounos, Jillian Michaels, Trevor Noah, Dak Prescott, Italia Ricci, Rob Riggle, Karla Souza, David Spade, Keith Urban, and Reese Witherspoon will all participate in this memorable event — marking 10 years since the first telecast and 10 years of SU2C’s lifesaving research achievements. Bradley Cooper will return as co-executive producer along with the renowned live-event producing team Done + Dusted, working again with the Stand Up To Cancer production team, after a successful partnership for the 2016 telecast. “As someone whose family has been significantly touched by cancer, I am proud to again have the privilege of co-executive producing this year’s Stand Up To Cancer telecast,” said Cooper. “This show reminds everyone that you are never alone… that there is a community of support out there when you need it most. That’s the power of SU2C. Most importantly, the telecast show...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health Only CBS Stand Up To Cancer Source Type: news

Related Links:

(Reuters Health) - - Nearly one in 10 cancer patients treated with chemotherapy or newer targeted drugs may be hospitalized for serious kidney injury, a Canadian study suggests.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Johnson&Johnson said on Monday it plans to buy back up to $5 billion of its stock, after a Reuters report on Friday that the company knew for decades that its Baby Powder contained cancer-causing asbestos wiped about $40 billion from its market value.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
SAN FRANCISCO - A cancer victim who accepted a reduced award of $78,506,418.35 in damages for exposure to glyphosate, the active ingredient in Monsanto Co.'s herbicide Roundup, on Nov. 2 filed a brief in California state court contending that Monsanto Co. should not be allowed to tax the costs the plaintiff seeks to recover after the trial because the costs are reasonable (DeWayne Johnson v. Monsanto Company, No. CGC 16550128, Calif. Super., San Francisco Co.).
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - Category: Medical Law Source Type: news
SAN FRANCISCO- The Judicial Panel on Multidistrict Litigation (JPMDL) on Nov. 14 issued an order transferring 15 additional cases to the U.S. District Court for the Northern District of California to be included in the multidistrict litigation for Roundup products. The plaintiffs all allege that exposure to glyphosate, the active ingredient in Roundup, caused them to develop cancer (In re: Roundup Products Liability Litigation, MDL No. 2741, JPMDL).
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - Category: Medical Law Source Type: news
OAKLAND, Calif. - A California state court judge on Nov. 15 granted a couple's motion for an expedited trial in their lawsuit against Monsanto Co., which they contend is liable for their cancer because they were exposed to glyphosate, the active ingredient in Monsanto's herbicide Roundup. The judge ordered the trial to begin March 18 (Alva Pilliod, et al. v. Monsanto Company, No. RG17862702, Calif. Super., Alameda Co.).
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - Category: Medical Law Source Type: news
SUMMARY Granulocytic sarcoma also called myeloid sarcoma is an extramedullary tumour of immature granulocytic cells. It is a rare entity, and mostly accompanied by acute myeloid leukaemia. It is observed during the course of myeloproliferative disorders especially in chronic myeloid leukaemia and myelodysplastic syndromes. Here, we report a case of a 60-year-old male with past history of myelofibrosis admitted to the emergency room due ulceronecrotic lesions, fever and dysphagia. We emphasize the importance of recognizing this entity and its severity.RESUMO O sarcoma granuloc ítico, também chamado de sarcoma ...
Source: Revista da Associacao Medica Brasileira - Category: General Medicine Source Type: research
SUMMARY Granulocytic sarcoma also called myeloid sarcoma is an extramedullary tumour of immature granulocytic cells. It is a rare entity, and mostly accompanied by acute myeloid leukaemia. It is observed during the course of myeloproliferative disorders especially in chronic myeloid leukaemia and myelodysplastic syndromes. Here, we report a case of a 60-year-old male with past history of myelofibrosis admitted to the emergency room due ulceronecrotic lesions, fever and dysphagia. We emphasize the importance of recognizing this entity and its severity.RESUMO O sarcoma granuloc ítico, também chamado de sarcoma ...
Source: Revista da Associacao Medica Brasileira - Category: General Medicine Source Type: research
Novocure (NSDQ:NVCR) today, along with the American Association for Cancer Research, announced four inaugural Tumor Treating Fields research grants totaling more than $1.5 million. The St. Helier, Jersey-based company said that the newly launched grants include the AACR-Novocure Tumor Treating Fields Research Grant, the AACR-Novocure Career Development Award for Tumor Treating Fields Research, the AACR-Novocure Tumor Treating Fields Research Fellowship and the AACR-Novocure Discovery Grant. The deadline for the grants closes on January 23, and will support research focused on preclinical ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Oncology Research & Development NovoCure Source Type: news
Ana Denae Colgin was diagnosed with leukemia and pneumonia in 2003 when her parents took her to the doctor with the flu. The now 21-year-old was once told that she only had days to live.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
At-home lab tests are growing in popularity. While many companies focus on specific tests, such as genetic testing or specific screenings, LetsGetChecked, a company with offices in New York, Dublin, and Toronto, hopes to be a central hub that al...
Source: Medgadget - Category: Medical Devices Authors: Tags: Diagnostics Exclusive Medicine Pathology Source Type: blogs
More News: Cancer | Cancer & Oncology | Cancer Therapy | Clinical Trials | Colon Cancer | Colorectal Cancer | Funding | Fundraising | Grants | Health | Immunotherapy | Laboratory Medicine | Leukemia | Melanoma | Men | Ovarian Cancer | Ovaries | Pancreas | Pancreatic Cancer | Partnerships | Prostate Cancer | Science | Skin Cancer | Sports Medicine | Study